Christopher Yea insider trades
Open-market stock purchases and sales by Christopher Yea, CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 21, 2016.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold (not open market) | $204K |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold (not open market) | $176K |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold (not open market) | — |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold (not open market) | $439K |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold (not open market) | $846K |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold (not open market) | $676K |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold (not open market) | $1.6M |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold (not open market) | $751K |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold (not open market) | $816K |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold (not open market) | — |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold (not open market) | — |
| May 27, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold | $905K |
| May 27, 2026 | KALV KalVista Pharmaceuticals, Inc | Bought (not open market) | — |
| May 26, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold | $52.6K |
| May 22, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold | $63.2K |
| May 22, 2026 | KALV KalVista Pharmaceuticals, Inc | Bought (not open market) | — |
| May 21, 2026 | KALV KalVista Pharmaceuticals, Inc | Bought (not open market) | — |
| May 18, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold | $29.7K |
| May 17, 2026 | KALV KalVista Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 23, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold | $67.7K |
| Feb 22, 2026 | KALV KalVista Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 21, 2026 | KALV KalVista Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 18, 2026 | KALV KalVista Pharmaceuticals, Inc | Sold | $16.6K |
| Feb 17, 2026 | KALV KalVista Pharmaceuticals, Inc | Bought (not open market) | — |
| Nov 24, 2025 | KALV KalVista Pharmaceuticals, Inc | Sold | $58.3K |
Companies traded
- KALV KalVista Pharmaceuticals, Inc: 51 sales, last Jun 11, 2026